Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Association of Testosterone Level among Lepromatous and Borderline Leprosy Male Patients: Experience of 30 Cases in Bangladesh

Mohammad AS, Mia T, Hamid M, et al. Bangladesh Journals Online (JOL). Bangladesh Journal of Infectious Diseases. 2021; 7 (2) : 36-39.
Publication

IL-6 promotes pathogenic Th17 in T1R leprosy reactions by stimulating Il17 producing by IL-6R pathway

Saini C, Srivastava R, Khanna N, et al. Elsevier BV. International Journal of Infectious Diseases. 2020;
Publication

Serum immune markers as triggers of reactional episodes in multibacillary patients with leprosy

Rêgo JL, Santana NDL, Aguiar ER, et al. Lepra. Leprosy Review. 2020; 91 (4) : 393-402.
Download PDF
Publication

Exploring the Dimensions of Health-related Stigma: Insights from narratives of people with stigmatized health conditions in Indonesia

Rai S. VU University. 2021;
Download PDF
Publication

Soluble mediators of immune significance in sera of leprosy patients

Dubey A, Gaur R, Arela N, et al. Lepra. Leprosy Review. 2020; 91 (4) : 403-412.
Download PDF
Publication

PERFIL CLÍNICO-NEUROLÓGICO DE PACIENTES COM HANSENÍASE

Neto MPL, Cunha FMBD, Gonçalves HDS, et al. Atena Editora. Frente Diagnóstica e Terapêutica na Neurologia 3. 2021;
Download PDF
Publication

Novartis renews WHO medicine donation pledge with aim of ending leprosy

Novartis . 2021;
Download PDF
Publication

It’s Time to Move Leprosy to the Annals of History

Gallo B. The Task Force for Global Health. 2021;
Download PDF
Publication

Aspectos epidemiológicos e espaciais de escolares avaliados na Campanha Nacional de Hanseníase em Sobral - Ceará, Brasil

Amaral VFD, Linhares MSC, Neto FRGX, et al. Conselho Federal de Enfermagem - Cofen. Enfermagem em Foco. 2020;
Download PDF
Publication

Healthcare professionals’ perceptions of community-based rehabilitation in KwaZulu-Natal, South Africa

Blose SB, Doeraj S, Padia S, et al. AOSIS. African Journal of Primary Health Care & Family Medicine. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 326
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD